Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid Arthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Management of Adults and Adolescents with Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Sickle Cell Disease Transition in Care
    Release Date:
    Partner: National Alliance of Sickle Cell Centers
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease USA
    2025 Rheumatology Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Invasive Mold Diseases (IMD) & Treatment Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom
    Implementing Updated RSV Immunization Recommendations for Older Adults
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Optimization of Health IT to support RSV Immunizations
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines USA
    New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Diagnosis and Risk Factors for Invasive Mold Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Best Practices for Drug-Drug Interactions (DDIs) Management for Oral COVID-19 Antivirals
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA